Affinity Asset Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.1M	Buy	1,950,000 +450,000	+30%	+$1.64M	0.97%	27
2025 Q1	$2.88M	Buy	+1,500,000	New	+$2.88M	0.27%	44